Frontier Energy tags a battery to its Waroona energy project following WA policy change
Frontier Energy includes four-hour, 80MW battery to Stage 1 of its Waroona renewable energy project Changes to WA state Government policy make inclusion of a [more…]
Ground Breakers: Is under-fire Evolution’s Canadian gold adventure too much hassle?
Evolution Mining shares plummeted almost 20% after second gold quarter production came in well below analyst expectations EVN has maintained full year guidance, but analysts [more…]
Meeka Metals confirms shallow oxide gold at St Anne’s, part of its bigger Murchison Gold Project
New intersections show wide zones, up to 31m width, of shallow oxide gold at the St Anne’s deposit in the Murchison Meeka has now submitted [more…]
ASX Health Stocks: Imugene gains on positive early signs from Phase 1 trial
Imugene reports positive early signs from Phase 1 CF33-hNIS Study Amplia says first patient dosed in Phase 2a portion of the ACCENT trial Imugene [more…]
Alicanto’s Falun project in Sweden might be much bigger than first thought
Latest drilling results suggest the size of its promising Skyttgruvan-Naverberg target is much larger than first thought Skyttgruvan-Naverberg is part of the same geological system [more…]
Termite mound sampling continues to pay off with Haranga defining two anomalies at Mandankoly
Infill termite mound sampling defines two uranium anomalies at Haranga’s Mandankoly prospect Five anomalies have now been defined by infill sampling across the Saraya uranium [more…]
Top 10 at 10: Pinnacle gains on uranium update, Evolution plummets
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. [more…]
Market Highlights: Wall Street falls on Fedspeak, the most crowded trades, and 5 ASX small caps to watch
ASX to open slightly lower after Wall Street fell overnight Fed’s Christopher Waller said the central bank won’t rush to cut rates And here are [more…]
PharmAust partners with US-based Berry Consultants for Phase 2/3 study
PharmAust partners with MND/ALS clinical study design and statistical analysis specialists Berry Consultants The US-based consultancy has a strong track record of clinical trial design [more…]
Taiton’s Kingsgate acquisition could be a route to near-term molybdenum production
Taiton is acquiring the Kingsgate project, which has proven high-grade molybdenum mineralisation Previous work includes extensive exploration and trial mining Molybdenum is now considered a [more…]